SLGL Valuation

Sol Gel Technologies Ltd

Add to Watchlist

Advanced Chart

15.440

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

SLGL Relative Valuation

SLGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SLGL is overvalued; if below, it's undervalued.

Historical Valuation

Sol Gel Technologies Ltd (SLGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.52 is considered Undervalued compared with the five-year average of -6.65. The fair price of Sol Gel Technologies Ltd (SLGL) is between 59.48 to 63.56 according to relative valuation methord. Compared to the current price of 15.44 USD , Sol Gel Technologies Ltd is Undervalued By 74.04%.

Relative Value

Fair Zone

59.48-63.56

Current Price：15.44

74.04%

Undervalued

-3.86

Trailing

Forward

2.55

EV/EBITDA

Sol Gel Technologies Ltd. (SLGL) has a current EV/EBITDA of 2.55. The 5-year average EV/EBITDA is -7.38. The thresholds are as follows: Strongly Undervalued below -38.63, Undervalued between -38.63 and -23.00, Fairly Valued between 8.24 and -23.00, Overvalued between 8.24 and 23.87, and Strongly Overvalued above 23.87. The current Forward EV/EBITDA of 2.55 falls within the Historic Trend Line -Fairly Valued range.

-2.18

EV/EBIT

Sol Gel Technologies Ltd. (SLGL) has a current EV/EBIT of -2.18. The 5-year average EV/EBIT is 7.45. The thresholds are as follows: Strongly Undervalued below -107.68, Undervalued between -107.68 and -50.11, Fairly Valued between 65.02 and -50.11, Overvalued between 65.02 and 122.58, and Strongly Overvalued above 122.58. The current Forward EV/EBIT of -2.18 falls within the Historic Trend Line -Fairly Valued range.

5.52

Sol Gel Technologies Ltd. (SLGL) has a current PS of 5.52. The 5-year average PS is 13.32. The thresholds are as follows: Strongly Undervalued below -25.61, Undervalued between -25.61 and -6.14, Fairly Valued between 32.79 and -6.14, Overvalued between 32.79 and 52.26, and Strongly Overvalued above 52.26. The current Forward PS of 5.52 falls within the Historic Trend Line -Fairly Valued range.

-6.34

P/OCF

Sol Gel Technologies Ltd. (SLGL) has a current P/OCF of -6.34. The 5-year average P/OCF is -15.76. The thresholds are as follows: Strongly Undervalued below -62.00, Undervalued between -62.00 and -38.88, Fairly Valued between 7.36 and -38.88, Overvalued between 7.36 and 30.48, and Strongly Overvalued above 30.48. The current Forward P/OCF of -6.34 falls within the Historic Trend Line -Fairly Valued range.

-4.62

P/FCF

Sol Gel Technologies Ltd. (SLGL) has a current P/FCF of -4.62. The 5-year average P/FCF is -10.73. The thresholds are as follows: Strongly Undervalued below -44.43, Undervalued between -44.43 and -27.58, Fairly Valued between 6.12 and -27.58, Overvalued between 6.12 and 22.97, and Strongly Overvalued above 22.97. The current Forward P/FCF of -4.62 falls within the Historic Trend Line -Fairly Valued range.

Sol Gel Technologies Ltd (SLGL) has a current Price-to-Book (P/B) ratio of 2.13. Compared to its 3-year average P/B ratio of 1.28 , the current P/B ratio is approximately 66.47% higher. Relative to its 5-year average P/B ratio of 2.44, the current P/B ratio is about -12.67% higher. Sol Gel Technologies Ltd (SLGL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -19.58%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -13.33% , the current FCF yield is about -100.00% lower.

2.13

P/B

Median3y

1.28

Median5y

2.44

0.00

FCF Yield

Median3y

-19.58

Median5y

-13.33

Competitors Valuation Multiple

The average P/S ratio for SLGL's competitors is 86.35, providing a benchmark for relative valuation. Sol Gel Technologies Ltd Corp (SLGL) exhibits a P/S ratio of 5.52, which is -93.61% above the industry average. Given its robust revenue growth of 121.24%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SLGL.O

Sol Gel Technologies Ltd

Jupiter Neurosciences Inc

126.74

42.70M

ACRV.O

Acrivon Therapeutics Inc

Can Fite Biopharma Ltd

Performance Decomposition

Market capitalization of SLGL increased by 120.92% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 466.00K to 1.03M.

The secondary factor is the P/E Change, contributed 36.93%to the performance.

Overall, the performance of SLGL in the past 1 year is driven by Revenue Growth. Which is more sustainable.

121.24%

466.00K → 1.03M

Revenue Growth

-37.25%

-1.36K → -854.32

Margin Expansion

36.93%

-2.41 → -3.30

P/E Change

120.92%